Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

477
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
477
Cancer02:18

Cancer

50.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
50.5K
Cancer Prevention02:59

Cancer Prevention

6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
What is Cancer?02:12

What is Cancer?

11.4K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
11.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

13.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
Cancer Vaccines01:30

Cancer Vaccines

546
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
546

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term trends in cancer mortality by rural-urban status, United States, 1969-2023.

Journal of the National Cancer Institute·2026
Same author

Colorectal cancer statistics, 2026.

CA: a cancer journal for clinicians·2026
Same author

Fatal Overdose, Acute Viral Hepatitis, and HIV Attributed to Injection Drug Use, Appalachian Region of the United States, 2000-2023.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Cancer statistics, 2026.

CA: a cancer journal for clinicians·2026
Same author

American Cancer Society's Report on the Status of Cancer Disparities in the United States, 2025.

CA: a cancer journal for clinicians·2025
Same author

Prostate cancer statistics, 2025.

CA: a cancer journal for clinicians·2025
Same journal

Serious mental illness and cancer: A call to action for equitable care.

CA: a cancer journal for clinicians·2026
Same journal

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026
Same journal

Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

CA: a cancer journal for clinicians·2026
Same journal

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

CA: a cancer journal for clinicians·2026
See all related articles

Related Experiment Video

Updated: Oct 7, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

408

Cancer statistics, 2022.

Rebecca L Siegel1, Kimberly D Miller1, Hannah E Fuchs1

  • 1Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia.

CA: a Cancer Journal for Clinicians
|January 12, 2022
PubMed
Summary
This summary is machine-generated.

Cancer survival rates show mixed progress. While lung cancer survival is improving due to early detection, breast and prostate cancer advancements have stalled, necessitating better screening and treatment strategies.

Keywords:
cancer casescancer statisticsdeath ratesincidencemortality

More Related Videos

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

466
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

239

Related Experiment Videos

Last Updated: Oct 7, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

408
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

466
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

239

Area of Science:

  • Oncology
  • Public Health
  • Epidemiology

Background:

  • The American Cancer Society provides annual estimates of cancer incidence and mortality in the U.S.
  • Data sources include the Surveillance, Epidemiology, and End Results (SEER) program, National Program of Cancer Registries (NPCR), North American Association of Central Cancer Registries (NAACCR), and National Center for Health Statistics (NCHS).

Purpose of the Study:

  • To present the latest U.S. cancer statistics for 2022, including projected cases and deaths.
  • To analyze trends in cancer incidence, mortality, and survival rates for major cancer types.
  • To evaluate progress in cancer control and identify areas for improvement.

Main Methods:

  • Utilized population-based cancer registry data for incidence (through 2018) and mortality (through 2019).
  • Analyzed trends in incidence rates, stage at diagnosis, and relative survival for female breast, prostate, and lung cancers.
  • Examined mortality trends in relation to incidence patterns.

Main Results:

  • Projected 1,918,030 new cancer cases and 609,360 deaths in the U.S. for 2022.
  • Female breast cancer incidence increased by 0.5% annually (2014-2018); prostate cancer incidence remained stable, but advanced disease increased.
  • Lung cancer incidence for advanced disease declined, while localized-stage incidence and survival rates significantly improved; mortality declines accelerated.

Conclusions:

  • Progress in reducing breast and prostate cancer mortality has stagnated.
  • Significant gains in lung cancer outcomes are linked to improved screening and treatment practices.
  • Enhanced cancer control interventions, early detection, and treatment are crucial for further reductions in cancer mortality.